Rifampicin-induced immune thrombocytopenia

Y. S. Mehta, F. F. Jijina, S. S. Badakere, A. V. Pathare, D. Mohanty

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Rifampicin-induced thrombocytopenia is reported in three patients with pulmonary tuberculosis. All three patients gave a definite history of having had prior exposure to rifampicin. Immunological studies in all three patients showed the presence of antiplatelet antibodies, resulting in thrombocytopenia. Moreover, binding of these antibodies to the platelet membrane was more avid in the presence of rifampicin, thereby implicating the drug. The avidity of the rifampicin-dependent antibodies was demonstrated by platelet aggregation inhibition test, and estimation of the rifampicin-dependent antibody was done by studying the platelet-associated immunoglobulin [PAlgG] by ELISA which was also used to quantitate antiplatelet antibodies. Immunofluorescence test was also performed to detect antiplatelet antibodies.

Original languageEnglish
Pages (from-to)558-562
Number of pages5
JournalTubercle and Lung Disease
Volume77
Issue number6
DOIs
Publication statusPublished - 1996

Fingerprint

Idiopathic Thrombocytopenic Purpura
Rifampin
Antibodies
Thrombocytopenia
Blood Platelets
Platelet Aggregation
Pulmonary Tuberculosis
Fluorescent Antibody Technique
Immunoglobulins
Enzyme-Linked Immunosorbent Assay
Membranes
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Immunology
  • Microbiology

Cite this

Mehta, Y. S., Jijina, F. F., Badakere, S. S., Pathare, A. V., & Mohanty, D. (1996). Rifampicin-induced immune thrombocytopenia. Tubercle and Lung Disease, 77(6), 558-562. https://doi.org/10.1016/S0962-8479(96)90056-8

Rifampicin-induced immune thrombocytopenia. / Mehta, Y. S.; Jijina, F. F.; Badakere, S. S.; Pathare, A. V.; Mohanty, D.

In: Tubercle and Lung Disease, Vol. 77, No. 6, 1996, p. 558-562.

Research output: Contribution to journalArticle

Mehta, YS, Jijina, FF, Badakere, SS, Pathare, AV & Mohanty, D 1996, 'Rifampicin-induced immune thrombocytopenia', Tubercle and Lung Disease, vol. 77, no. 6, pp. 558-562. https://doi.org/10.1016/S0962-8479(96)90056-8
Mehta, Y. S. ; Jijina, F. F. ; Badakere, S. S. ; Pathare, A. V. ; Mohanty, D. / Rifampicin-induced immune thrombocytopenia. In: Tubercle and Lung Disease. 1996 ; Vol. 77, No. 6. pp. 558-562.
@article{c7c8a63bec94400ab0a6e2f3739e00e8,
title = "Rifampicin-induced immune thrombocytopenia",
abstract = "Rifampicin-induced thrombocytopenia is reported in three patients with pulmonary tuberculosis. All three patients gave a definite history of having had prior exposure to rifampicin. Immunological studies in all three patients showed the presence of antiplatelet antibodies, resulting in thrombocytopenia. Moreover, binding of these antibodies to the platelet membrane was more avid in the presence of rifampicin, thereby implicating the drug. The avidity of the rifampicin-dependent antibodies was demonstrated by platelet aggregation inhibition test, and estimation of the rifampicin-dependent antibody was done by studying the platelet-associated immunoglobulin [PAlgG] by ELISA which was also used to quantitate antiplatelet antibodies. Immunofluorescence test was also performed to detect antiplatelet antibodies.",
author = "Mehta, {Y. S.} and Jijina, {F. F.} and Badakere, {S. S.} and Pathare, {A. V.} and D. Mohanty",
year = "1996",
doi = "10.1016/S0962-8479(96)90056-8",
language = "English",
volume = "77",
pages = "558--562",
journal = "Tuberculosis",
issn = "1472-9792",
publisher = "Churchill Livingstone",
number = "6",

}

TY - JOUR

T1 - Rifampicin-induced immune thrombocytopenia

AU - Mehta, Y. S.

AU - Jijina, F. F.

AU - Badakere, S. S.

AU - Pathare, A. V.

AU - Mohanty, D.

PY - 1996

Y1 - 1996

N2 - Rifampicin-induced thrombocytopenia is reported in three patients with pulmonary tuberculosis. All three patients gave a definite history of having had prior exposure to rifampicin. Immunological studies in all three patients showed the presence of antiplatelet antibodies, resulting in thrombocytopenia. Moreover, binding of these antibodies to the platelet membrane was more avid in the presence of rifampicin, thereby implicating the drug. The avidity of the rifampicin-dependent antibodies was demonstrated by platelet aggregation inhibition test, and estimation of the rifampicin-dependent antibody was done by studying the platelet-associated immunoglobulin [PAlgG] by ELISA which was also used to quantitate antiplatelet antibodies. Immunofluorescence test was also performed to detect antiplatelet antibodies.

AB - Rifampicin-induced thrombocytopenia is reported in three patients with pulmonary tuberculosis. All three patients gave a definite history of having had prior exposure to rifampicin. Immunological studies in all three patients showed the presence of antiplatelet antibodies, resulting in thrombocytopenia. Moreover, binding of these antibodies to the platelet membrane was more avid in the presence of rifampicin, thereby implicating the drug. The avidity of the rifampicin-dependent antibodies was demonstrated by platelet aggregation inhibition test, and estimation of the rifampicin-dependent antibody was done by studying the platelet-associated immunoglobulin [PAlgG] by ELISA which was also used to quantitate antiplatelet antibodies. Immunofluorescence test was also performed to detect antiplatelet antibodies.

UR - http://www.scopus.com/inward/record.url?scp=0030451601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030451601&partnerID=8YFLogxK

U2 - 10.1016/S0962-8479(96)90056-8

DO - 10.1016/S0962-8479(96)90056-8

M3 - Article

VL - 77

SP - 558

EP - 562

JO - Tuberculosis

JF - Tuberculosis

SN - 1472-9792

IS - 6

ER -